Bactiguard Holding AB (publ) (FRA:5JE)

Market Cap	53.73M
Revenue (ttm)	19.70M
Net Income (ttm)	-1.92M
Shares Out	n/a
EPS (ttm)	-0.05
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	n/a
Open	1.305
Previous Close	1.310
Day's Range	1.305 - 1.305
52-Week Range	1.255 - 3.390
Beta	n/a
RSI	43.42
Earnings Date	Feb 5, 2026

About Bactiguard Holding AB

Bactiguard Holding AB (publ), a medTech company, provides infection prevention technology and solutions in orthopedics, cardiology, neurology, urology, and vascular access areas. It also operates through license partnerships with global MedTech companies that apply the technology to medical devices and sell them under own brand and co-branded. The company also has a portfolio of wound management products, such as Hydrocyn Aqua, an antimicrobial solution and gel for improved wound healing; and surgical sutures comprising non-absorbable, natural ...

• Industry: Orthopedic, Prosthetic, and Surgical Appliances and Supplies
• Founded: 2005
• Employees: 177
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 5JE

Financial Performance

In 2024, Bactiguard Holding AB's revenue was 243.68 million, an increase of 19.46% compared to the previous year's 203.99 million. Losses were -29.82 million, -78.45% less than in 2023.

Financial numbers in SEK